In terms of provisions of Regulation 30 (read with Part A of Schedule III) and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ( Listing Regulations ), we wish to inform you that the Board of Directors of the Company, at its meeting held today i.e. 4th May, 2026, inter-alia, has identified and designated Ms. Annapurna Das, President (India Business & Emerging Markets (NCE)), Mr. Om Narayan, Senior Vice President (Biotech Research Centre) and Mr. Sunil Soni, Senior Vice President (Biotechnology) as Senior Management Personnel of the Company.